Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0001209191-20-003273

Options or other derivatives

  • Director acquired 25,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Desjardins Clarissa Director 2020-01-13 Grant or award · Stock Option (Right to Buy) +25,000 25,000 D
Loading xslF345X03/doc4.xml…